In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  gamma-secretase/Notch signalling pathway inhibitor RO4929097
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02509, CDR0000683099, ABTC-1002, U01CA137443, NCT01189240

2.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02524, CDR0000684220, 10-085, 8491, U01CA069856, N01CM62206, MSKCC-10085, NCT01196416

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NP22383, 2008-006384-37, NCT01070927

4.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02040, SWOG-S0933, CDR0000671815, S0933, U10CA032102, NCT01120275

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02845, MCC 16221, N01CM17102, NCT01116687

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03068, PHL-077, 8563, N01CM00032, NCT01141569

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03069, PHL-079, 8635, N01CM00032, N01CM00071, N01CM00038, PMH-PHL-079, NCT01175343

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02527, CINJ-081001, CDR0000684276, 081001, 8576, NCT01200810

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02537, CDR0000687335, UCHSC-10-0273, 10-0273, 8490, U01CA070095, P30CA046934, NCT01232829

10.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NO21321, NCT00532090

11.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02064, CDR0000662081, 2009-099, 8420, U01CA062487, U01CA070095, P30CA022453, WSU-2009-099, NCT01071564

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01550, CDR0000666959, PMH-PJC-003, PJC-003, 8501, U01CA132123, NCT01096355

13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-2011-01410, CDR0000672641, 09-177, 8556, U01CA069856, P30CA008748, MSKCC-09177, NCT01119599

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01428, CDR0000673867, PJC-004, 8503, U01CA132123, CAN-OCI-PJC-004, NCT01131234

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01433, CDR0000674950, PHL-078, 8575, U01CA132123, PMH-PHL-078, NCT01145456

16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02918, CDR0000680610, CO09907, 8515, P30CA014520, U01CA062491, U01CA132123, WCCC-CO09907, NCT01158274

17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2010-01975, CDR0000684271, MDA-2009-0769, 2009-0769, 8508, NCT01193881

18.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02529, 8500, CDR0000684714, PJC-005, U01CA132123, PMH-PJC-005, NCT01198184

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02916, CDR0000685426, CO09908, 8516, P30CA014520, U01CA062491, WCCC-CO-09908, NCT01218620

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-03813, CDR0000687152, OSU-OH007, OSU 10011, 8518, U01CA076576, OH007, NCT01238133
New Search